4 Einträge gefunden

1. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results

   1. Hauser, Ingeborg A
   2. Marx, Stefanie
   3. Sommerer, Claudia
   4. Suwelack, Barbara
   5. Dragun, Duska
   6. Witzke, Oliver
   7. Lehner, Frank

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients

   1. Sommerer, Claudia
   2. Suwelack, Barbara
   3. Dragun, Duska
   4. Schenker, Peter
   5. Hauser, Ingeborg A
   6. Witzke, Oliver
   7. Hugo, Christian

   2019 - Forschungsinformationssystem des UKE
3. Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy

   1. Sommerer, Claudia
   2. Duerr, Michael
   3. Witzke, Oliver
   4. Lehner, Frank
   5. Arns, Wolfgang
   6. Kliem, Volker
   7. Ackermann, Daniel

   2018 - Forschungsinformationssystem des UKE
4. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients,study protocol for a randomised controlled trial

   1. Sommerer, Claudia
   2. Suwelack, Barbara
   3. Dragun, Duska
   4. Schenker, Peter
   5. Hauser, Ingeborg A
   6. Nashan, Björn
   7. Thaiss, Friedrich

   2016 - Forschungsinformationssystem des UKE - frei zugänglich